EP
IRMD icon

Essential Partners’s iRadimed IRMD Stock Holding History

Essential Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.54K Hold
41
– – ﹤0.01% 1672
2026
Q2 		$3.92K Hold
41
– – ﹤0.01% 1651
2026
Q1 		$3.95K Hold
41
– – ﹤0.01% 1695
2025
Q4 		$3.99K Buy
41
+3
+8% +$257 ﹤0.01% 1526
2025
Q3 		$2.7K Buy
38
+20
+111% +$1.33K ﹤0.01% 1689
2025
Q2 		$1.08K Buy
+18
New +$987 ﹤0.01% 1493

Other funds holding IRMD

Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Davidson Capital Management
Davidson Capital Management Corpus Christi, Texas $604M AUM 18.09% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Essential Partners's IRMD Position: Q3 2026 in Review

Essential Partners held its iRadimed (IRMD) position steady in Q3 2026 at 41 shares worth $3.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Essential Partners first reported a position in IRMD in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.99K in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Essential Partners held 41 shares of iRadimed worth $3.54K as of Q3 2026.
  • Essential Partners left its iRadimed share count unchanged in Q3 2026.
  • iRadimed made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1672 holding.
  • Essential Partners first reported a position in iRadimed in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's iRadimed position peaked at $3.99K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.